Skip to main content

Table 3 Change of CT Scores Throughout Treatment of Initial NTM Lung Disease and Isolation of New NTM

From: Implication of species change of Nontuberculous Mycobacteria during or after treatment

 

At initiation of treatment

At 6–12 months after treatment

At isolation of new NTM

At 6–12 months after isolation of new NTM

P Value

Bronchiectasis,

 Severity

1.7 (1-2)

1.8 (1.2-2)

2 (1.2-2)

1.7 (1.3-2)

.572

 Extent

1 (1-2)

1 (1-2)

1 (1-2)

1 (1-2)

.733

 Mucus plugging

1 (0-1)

0 (0-1)

1 (0-1)

1 (0-1)

.875

Cellular bronchiolitis

 Severity

1.8 (1.6-2.2)

1.7 (1.2-2)

2 (1.6-2)

1.8 (1.7-2)

.089

 Extent

3 (1-3)

2.5 (1-3)

2 (1.5-3)

2 (1-3)

.112

Cavity

 Diameter (cm)

1 (0-2)

0 (0-1)

1 (0-1)

1 (0-2)

.245

 Wall thickness (mm)

2 (0-2.5)

0 (0-2.1)

2 (0-2)

0.5 (0-2.4)

.978

 Extent

1 (0-1)

0 (0-1)

1 (0-1)

1 (0-1)

1.000

Nodules

1 (0-1)

1 (0.8-1)

1 (1-1.5)

1 (0-1)

.572

Consolidation

0 (0-1)

0 (0-0.3)

0 (0-1)

1 (0-1)

.479

Total CT score

13.2 (7.2-17.6)

9.6 (6.4-14.4)

12.9 (9.0-14.8)

13 (8.0-14.6)

.794

  1. Data are expressed as median (IQR). CT computed tomography, NTM nontuberculous mycobacteria